Meenhard Herlyn
cancer researcher
Meenhard Herlyn is an American researcher who works as director of the Wistar Institute Melanoma Research in Philadelphia. Herlyn obtained his D.V.M. degree from the University of Veterinary Medicine Hannover in 1970. Following that, in 1976, he earned a D.Sc. in medical microbiology from LMU Munich. In 1976, he joined the Wistar Institute as an associate scientist, focusing on the emerging field of monoclonal antibodies—a groundbreaking technology that now underlies a significant portion of targeted therapeutics. Transitioning to the role of assistant professor in 1981, Herlyn established a renowned laboratory dedicated to studying melanoma biology, which remains highly regarded in the field to this day. His primary research focus is the underlying biology behind melanoma, the most aggressive form of skin cancer. Over the course of his career, he has been responsible for the use of three-dimensional artificial skin cultures to study tumor and normal cells, a clearer understanding of stem cells and how they relate to cancer, and signaling pathways related to cancer. The Wistar Melanoma (WM) cell lines that Herlyn has used and helped discover in his laboratory are responsible for a better understanding of the major steps of tumor progression in human cases of melanoma.
In 2003, Herlyn helped launch the first International Melanoma Research Congress in Philadelphia, the first scientific meeting specifically aimed at melanoma scientists.
The public source identifies “Meenhard Herlyn” as cancer researcher. This brief keeps that definition visible, then builds a research path around Meenhard, Herlyn and cancer.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Meenhard Herlyn”, the useful work is to connect “cancer researcher” to the records capable of establishing context and consequence.
Biographical claims are most persuasive when dates, appointments and relationships can be traced to records created close to the events described. The source revision retrieved here is dated Sep 26, 2026. The linked authority identifier is Q16732421. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1970, 1976, 1981 and 2003.
Later biographies can compress uncertainty and repeat inherited reputations, so apparently settled claims may still require comparison. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Read biographical claims against dates, named institutions and the cited references. Distinguish a subject’s later reputation from evidence produced during their lifetime.
- Establishing names and roles
- Building a first chronology
- Locating cited institutions
Personal papers, civil or court records, institutional files and the scholarship cited by the source.
Three-step research path
- Establish the record: confirm the title “Meenhard Herlyn”, its source revision and the description used here.
- Expand the search: follow Meenhard Herlyn primary sources, Meenhard Herlyn archive and Meenhard research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Meenhard Herlyn”?
- How has the subject’s reputation changed across later accounts?
- Which claims depend on a single source or contested interpretation?
Search terms from this dossier
This entry incorporates text from “Meenhard Herlyn” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.